|
Market Closed -
Bombay S.E.
09:02:30 20/11/26 pm AEDT
|
5-day change | 1st Jan Change | ||
| 63.79 INR | -7.55% |
|
-11.40% | +18.94% |
Company Valuation: Colinz Laboratories Limited
Data adjusted to current consolidation scope
| Fiscal Period: March | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|
| Market Cap 1 | 34.74 | 107.6 | 160 | 94.59 | 182.5 | 112.1 |
| Change | - | 209.87% | 48.62% | -40.87% | 92.92% | -38.57% |
| Enterprise Value (EV) 1 | -2.149 | 60.43 | 105.4 | 30.29 | 133.4 | 30.71 |
| Change | - | 2,911.96% | 74.47% | -71.27% | 340.39% | -76.98% |
| P/E | 16.7x | 31.8x | 19.2x | 19.5x | 36.8x | 21.8x |
| PBR | 0.48x | 1.4x | 1.08x | 1.06x | 1.93x | 1.12x |
| PEG | - | 0.5x | 0x | 3.23x | 17.76x | 6.14x |
| Capitalization / Revenue | 0.56x | 1.54x | 2.24x | 1.35x | 2.8x | 1.83x |
| EV / Revenue | -0.03x | 0.87x | 1.47x | 0.43x | 2.04x | 0.5x |
| EV / EBITDA | -0.65x | 10.3x | 16.7x | 5.58x | 26.9x | 7.54x |
| EV / EBIT | -1.52x | 15.7x | 20.9x | 7.34x | 36.7x | 12.2x |
| EV / FCF | -0.2x | 8.87x | 17.8x | 4.12x | -7.62x | 1.07x |
| FCF Yield | -506% | 11.3% | 5.62% | 24.3% | -13.1% | 93% |
| Dividend per Share 2 | - | - | - | - | - | - |
| Rate of return | - | - | - | - | - | - |
| EPS 2 | 0.4541 | 0.74 | 1.82 | 1.93 | 1.97 | 2.04 |
| Distribution rate | - | - | - | - | - | - |
| Net sales 1 | 61.59 | 69.74 | 71.55 | 70.3 | 65.28 | 61.36 |
| EBITDA 1 | 3.331 | 5.862 | 6.326 | 5.428 | 4.951 | 4.075 |
| EBIT 1 | 1.418 | 3.85 | 5.037 | 4.125 | 3.639 | 2.512 |
| Net income 1 | 2.076 | 3.393 | 4.574 | 4.867 | 4.966 | 5.145 |
| Net Debt 1 | -36.89 | -47.22 | -54.55 | -64.3 | -49.09 | -81.39 |
| Reference price 2 | 7.60 | 23.55 | 35.00 | 37.55 | 72.44 | 44.50 |
| Nbr of stocks (in thousands) | 4,571 | 4,571 | 4,571 | 2,519 | 2,519 | 2,519 |
| Announcement Date | 30/8/21 | 24/8/22 | 29/8/23 | 29/8/24 | 28/8/25 | 20/8/26 |
1INR in Million2INR
Estimates
| P/E (Y) | EV / Sales (Y) | EV / EBITDA (Y) | Dividend Yield (Y) | Capi.($) | ||
|---|---|---|---|---|---|---|
| - | - | - | - | 1.86M | ||
| 39.52x | 13.4x | 28.41x | 0.5% | 1,204B | ||
| 36.48x | 6.57x | 18.48x | 1.99% | 643B | ||
| 36.15x | 8.33x | 17.22x | 2.43% | 501B | ||
| 21.54x | 5.2x | 13.03x | 2.51% | 378B | ||
| 94.27x | 5.43x | 23.16x | 2.56% | 327B | ||
| 22.77x | 5.51x | 13.41x | 2.89% | 285B | ||
| 22.87x | 4.6x | 13.08x | 1.92% | 270B | ||
| 22.66x | 7.01x | 12.88x | 2.3% | 237B | ||
| -39.16x | 7.25x | 45.68x | 1.98% | 207B | ||
| Average | 28.57x | 7.03x | 20.59x | 2.12% | 405B | |
| Weighted average by Cap. | 34.08x | 8.45x | 21.48x | 1.77% |
Y-o-Y evolution of P/E
Historical PBR trend
Evolution Enterprise Value / Sales
Change in Enterprise Value/EBITDA
- Stock Market
- Stocks
- COLINZ6 Stock
- Valuation Colinz Laboratories Limited
Select your edition
All financial news and data tailored to specific country editions
















